Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study

ConditionMonkeypox

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

About this trial

This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.

Eligibility criteria

Qualifiers

Adult individuals of ≥18 years old.

Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial.

Has understood the information provided and capable of giving informed consent.

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

100 Participants

are grouped into 2 trial groups

Sponsors and collaborators

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Lead sponsor

IrsiCaixa

Collaborator

BCN Checkpoint

Collaborator

Source ClinicalTrials.gov